Validation of the Greek Postoperative Quality of Recovery Score 15
Launched by IASO THESSALIAS · Nov 19, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on making sure a questionnaire that helps measure how well patients recover after surgery is useful for Greek-speaking patients. The study will translate the original questionnaire into Greek and check if it works well, is easy to understand, and can be used comfortably by patients after their surgeries. The aim is to ensure that this tool accurately reflects patients' recovery experiences so that healthcare providers can better support them.
To be eligible for this study, participants should be over 18 years old and scheduled for elective (planned) general surgery where they will be put under general anesthesia. Unfortunately, people who are having emergency surgeries, have trouble understanding Greek, or have certain medical conditions that may affect their ability to participate won’t be included. If you join the study, you will help researchers understand how to better evaluate recovery in Greek-speaking patients, which could improve care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>18 years old
- • Scheduled elective general surgery under general anesthesia
- Exclusion Criteria:
- • Emergency surgery
- • Poor Greek comprehension
- • Inability to give consent
- • A psychiatric or neurological condition that precludes cooperation
- • Known history of alcohol or drug dependence
- • Life-threatening postoperative complications
- • Postoperative admission to ITU
About Iaso Thessalias
IASO Thessalias is a leading clinical trial sponsor dedicated to advancing medical research and innovation. Based in Thessaly, Greece, the organization specializes in the development and management of clinical trials across various therapeutic areas, including oncology, cardiology, and neurology. Committed to rigorous scientific standards and ethical practices, IASO Thessalias collaborates with healthcare professionals, research institutions, and pharmaceutical companies to ensure the successful execution of clinical studies. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, IASO Thessalias plays a vital role in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Larissa, Thessaly, Greece
Patients applied
Trial Officials
DESPOINA LIOTIRI, ANAESTHESIOLOGIST
Principal Investigator
IASO THESSALIAS GENERAL HOSPITAL
DIMITRIOS ZACHAROULIS, PROFESSOR OF SURGERY
Study Chair
University of Thessaly
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported